Type IV Hypersensitivity (Delayed/Cellular)

Type IV (delayed) hypersensitivity is mediated by sensitised T cells rather than antibodies. Reactions develop over hours to days as antigen-specific T cells release cytokines and recruit macrophages, or as cytotoxic T cells directly kill target cells, producing the characteristic delayed tissue inflammation.

Definition

Type IV hypersensitivity is delayed, T cell-mediated tissue injury in which sensitised CD4+ or CD8+ T cells respond to antigen by releasing cytokines that activate macrophages and drive inflammation, or by directly killing target cells, over a course of hours to days.

Scope

This entry covers the cell-mediated mechanisms of delayed hypersensitivity: antigen presentation to memory T cells, cytokine-driven macrophage activation, granuloma formation in persistent reactions, and direct cytotoxic T-cell killing. It is a mechanistic reference within immunopathology and is not clinical guidance.

Core questions

• Why does the reaction take hours to days rather than minutes?
• How do CD4+ T cells recruit and activate macrophages to cause injury?
• When does persistent antigen lead to granuloma formation?
• How do CD8+ cytotoxic T cells contribute to tissue damage?

Key concepts

• Sensitised CD4+ and CD8+ T cells
• Cytokine release and macrophage activation
• Delayed tempo (24-72 hours)
• Granuloma formation in chronic antigen exposure
• Cytotoxic T-cell killing
• Tuberculin (Mantoux) reaction
• Allergic contact dermatitis

Mechanisms

Unlike the antibody-mediated types, Type IV reactions depend on previously sensitised T cells. On re-encountering antigen presented by antigen-presenting cells, memory CD4+ T cells release cytokines such as interferon-gamma that activate macrophages, amplifying inflammation; recruited and activated macrophages cause much of the tissue injury. When antigen persists and cannot be cleared, sustained activation produces granulomas. In a parallel pathway, CD8+ cytotoxic T cells recognise antigen on target cells and kill them directly. Because these cellular events require recruitment and activation over time, the reaction characteristically peaks 24 to 72 hours after exposure.

Clinical relevance

Delayed hypersensitivity underlies the tuberculin skin test, allergic contact dermatitis, granulomatous responses to persistent organisms, certain drug eruptions, and aspects of transplant rejection and some autoimmune diseases. The entry describes the mechanism and its clinical correlates for orientation and is not a guide to diagnosis or treatment.

Epidemiology

Cell-mediated reactions are encountered across diverse settings, from the widely used tuberculin test to common allergic contact dermatitis; the frequency of specific delayed-hypersensitivity disorders varies and is addressed in the relevant entries.

Evidence & guidelines

The mechanistic account is drawn from immunology textbooks and disease reviews; condition-specific evidence and guidance lie in the relevant clinical entries.

History

Delayed cellular reactivity was recognised in Koch's late-nineteenth-century observations of the tuberculin reaction, providing an early demonstration of cell-mediated immune injury that was later classified as Type IV in the Gell and Coombs scheme.

Debates

Should Type IV be subdivided?

Modern understanding of distinct T-helper subsets and cytotoxic mechanisms has led some authors to subdivide delayed hypersensitivity into categories (for example IVa-IVd) reflecting different effector cells and cytokines, although the single Type IV category remains standard in basic teaching.

Key figures

• Robin Coombs
• Philip Gell
• Robert Koch

Seminal works

• coombs-gell-1963

Frequently asked questions

Why is Type IV hypersensitivity delayed?

Because it depends on recruiting and activating antigen-specific T cells and macrophages rather than on preformed antibody; this cellular process takes time, so the reaction typically peaks one to three days after exposure.

What is a classic test of delayed hypersensitivity?

The tuberculin (Mantoux) skin test, in which intradermal antigen produces an induration that is read at 48 to 72 hours, is a standard demonstration of cell-mediated delayed hypersensitivity.